{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:34:09Z","timestamp":1790696049285,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.humpath.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T13:05:38Z","timestamp":1524488738000},"page":"97-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Bim is an independent prognostic marker in intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"78","author":[{"given":"Henan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang-Ta","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuogang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2018.04.009_bb0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection","volume":"248","author":"Endo","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.humpath.2018.04.009_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.humpath.2018.04.009_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1535-6108(02)00127-7","article-title":"Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics","volume":"2","author":"Letai","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2018.04.009_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nri1568","article-title":"The role of BH3-only proteins in the immune system","volume":"5","author":"Strasser","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.humpath.2018.04.009_bb0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ceb.2005.10.001","article-title":"Life in the balance: how BH3-only proteins induce apoptosis","volume":"17","author":"Willis","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.humpath.2018.04.009_bb0030","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1038\/sj.onc.1205327","article-title":"Dysregulation of apoptosis genes in hematopoietic malignancies","volume":"21","author":"Kitada","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2018.04.009_bb0035","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.0401471101","article-title":"Bim is a suppressor of Myc-induced mouse B cell leukemia","volume":"101","author":"Egle","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2018.04.009_bb0040","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","article-title":"Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM","volume":"24","author":"Tagawa","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2018.04.009_bb0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.jid.5700989","article-title":"Bim expression is reduced in human cutaneous melanomas","volume":"128","author":"Dai","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2018.04.009_bb0050","first-page":"2976","article-title":"Identification and characterization of Bimgamma, a novel proapoptotic BH3-only splice variant of Bim","volume":"62","author":"Liu","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2018.04.009_bb0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ccr.2005.02.008","article-title":"Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy","volume":"7","author":"Tan","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2018.04.009_bb0060","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/sj.cdd.4401688","article-title":"Regulatory phosphorylation of Bim: sorting out the ERK from the JNK","volume":"12","author":"Ley","year":"2005","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.humpath.2018.04.009_bb0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3748\/wjg.v16.i6.713","article-title":"Involvement of PI3K and ERK1\/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion","volume":"16","author":"Menakongka","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.humpath.2018.04.009_bb0070","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1158\/1078-0432.CCR-07-5202","article-title":"Prognostic impact of bim, puma, and noxa expression in human colon carcinomas","volume":"14","author":"Sinicrope","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2018.04.009_bb0075","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1038\/sj.onc.1210510","article-title":"Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance","volume":"26","author":"Zantl","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2018.04.009_bb0080","author":"Washington"},{"key":"10.1016\/j.humpath.2018.04.009_bb0085","article-title":"T cell Bim levels reflect responses to anti-PD-1 cancer therapy","volume":"1-14","author":"Dronca","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.humpath.2018.04.009_bb0090","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cellsig.2011.08.018","article-title":"CDK1, not ERK1\/2 or ERK5, is required for mitotic phosphorylation of BIMEL","volume":"24","author":"Gilley","year":"2012","journal-title":"Cell Signal"},{"key":"10.1016\/j.humpath.2018.04.009_bb0095","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/cdd.2013.93","article-title":"BimEL is phosphorylated at mitosis by Aurora A and targeted for degradation by betaTrCP1","volume":"20","author":"Moustafa-Kamal","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.humpath.2018.04.009_bb0100","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fonc.2015.00278","article-title":"Aurora kinase inhibitors: current status and outlook","volume":"5","author":"Bavetsias","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2018.04.009_bb0105","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1038\/onc.2014.313","article-title":"Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2","volume":"34","author":"Merino","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2018.04.009_bb0110","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.celrep.2014.07.057","article-title":"BIM is the primary mediator of MYC-induced apoptosis in multiple solid tissues","volume":"8","author":"Muthalagu","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.humpath.2018.04.009_bb0115","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1158\/1535-7163.MCT-09-0685","article-title":"Bim-targeted cancer therapy: a link between drug action and underlying molecular changes","volume":"8","author":"Akiyama","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.humpath.2018.04.009_bb0120","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/2159-8290.CD-11-0106","article-title":"BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors","volume":"1","author":"Faber","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2018.04.009_bb0125","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/sj.onc.1208421","article-title":"Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl\u2013expressing cells","volume":"24","author":"Essafi","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2018.04.009_bb0130","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.4161\/cc.6.18.4728","article-title":"Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels","volume":"6","author":"Ewings","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2018.04.009_bb0135","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4161\/cbt.6.4.4226","article-title":"Proteasome inhibition specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteins","volume":"6","author":"Pigneux","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.humpath.2018.04.009_bb0140","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cell.2007.01.021","article-title":"Chemical genetics: where genetics and pharmacology meet","volume":"128","author":"Knight","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2018.04.009_bb0145","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1128\/MCB.01481-08","article-title":"Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1","volume":"29","author":"Chen","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2018.04.009_bb0150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1158\/1078-0432.CCR-07-1934","article-title":"Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells","volume":"14","author":"Dai","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2018.04.009_bb0155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00192-007-0498-2","article-title":"The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial","volume":"19","author":"Visco","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.humpath.2018.04.009_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040294","article-title":"Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas","volume":"4","author":"Gong","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.humpath.2018.04.009_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.227","article-title":"Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway","volume":"7","author":"Chi","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.humpath.2018.04.009_bb0170","doi-asserted-by":"crossref","first-page":"22384","DOI":"10.1074\/jbc.M111.239566","article-title":"Bim protein degradation contributes to cisplatin resistance","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2018.04.009_bb0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12929-017-0329-9","article-title":"Cancer immunotherapies targeting the PD-1 signaling pathway","volume":"24","author":"Iwai","year":"2017","journal-title":"J Biomed Sci"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718301291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718301291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T09:11:36Z","timestamp":1533633096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817718301291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":35,"alternative-id":["S0046817718301291"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2018.04.009","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bim is an independent prognostic marker in intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}